INTRODUCTION

Pentachlorophenol
(PCP) is widely used as a biocide, although, its usage is limited to restricted regions in Japan because of its strong toxicity to fishes. With regard to the biochemical aspects of PCP toxicity, Weinbach1) found that PCP inhibited oxidative phosphorylation in vitro and postulated that the inhibition was at least partly responsible for the toxic effects of PCP. Since then, biochemical interest has been focused on this uncoupling action of On the other hand, an elevation of blood sugar has been demonstrated to be a characteristic response in the PCP-treated animals.
Kehoe et al. observed that treatment with PCP increased blood glucose levels in rabbits.10) McGavack et al. showed early elevation and later depression of blood glucose in rabbits after subcutaneous application of PCP.11) Deichmann et al. also found high levels of blood sugar in all species of animals studied.12) Similar increases in serum glucose levels were also observed in treated rats.13) More recently, Fox and Rao investigated PCP effects on enzyme activities associated with the TCA-cycle in blue crab.14) Despite these experiments, a decisive conclusion on the mechanism of increase in blood glucose levels induced by PCP has not yet been obtained.
Furthermore,
few studies have been conducted on PCP influences on glycogen metabolism. In an earlier report, the authors demonstrated that a single oral administration of PCP caused a marked effect on rat hepatic glycogen storage 24 hours after dosing.15) Present studies aim to clarify in more detail PCP effects on the several parameters associated with glycogen metabolism. In addition, the activities of glycogen synthetase and phosphorylase in the liver of rats with PCP have been determined and compared with those of the controls.
MATERIALS AND METHODS
Male Wstar rats, weighing 200 to 300g, were used throughout the experiments.
The PCP, 90% pure as sodium salt from Wako Pure Chemicals, was dissolved in distilled water and administered at a dose of 120mg/kg via a stomach tube. Control rats received an equivalent volume of distilled water. All animals were put on a fast immediately after the single oral administration of PCP to avoid differences in food intake and absorption between control and PCP-treated rats. Because of the known circadian changes in liver glycogen, the animals were killed at a fixed time of 10a.m.
Under pentobarbital anesthesia (50mg/kg ip), blood was obtained by cardiac puncture with a heparinized syringe and used for biochemical examination. scintillation counter after addition of 10ml of scintillation cocktail prepared by dissolving 4g of 2,5-diphenyloxazole and 0.1g of 1,4-bis-[2-(5-phenyloxazolyl)]-benzene in 1l of toluene. One unit of enzyme was defined as the amount which catalyzed the incorporation of one nmole of glucose per minute per mg protein under the assay conditions. Phosphorylase activity was determined by measuring the inorganic phosphate contents released from glucose-1-phosphate under the conditions of assay. 24) Protein was measured by the method of Lowry et al.25) after precipitation with 10% trichloroacetic acid to eliminate turbidity due to glycogen.
Serum corticosterone (SCS) was assayed fluorometrically as described by Steenburg and Thomasson.26) Adrenal corticosterone (ACS) was estimated in the same way as SCS after the right adrenal gland was homogenized with 2ml of 33% ethyl alcohol. The method of Roe and Kuether27) was employed to determine the adrenal ascorbic acid (AAA) level using the left adrenal gland. a: PCP was administered at a single po dose of 120mg/kg to male Wistar rats. Control received an equivalent volume of distilled water. The rats were put on a fast and killed at the stated time intervals.
Values represent the mean±standard error followed by the number of animals in parenthesis. Table  2 Effects of PCP on the levels of liver glycogen and blood sugar in ratsa.
a: PCP was administered at a single po dose of 120mg/kg to male Wistar rats. Control received an equivalent volume of distilled water. The rats were put on a fast and killed at the stated time intervals.
Values represent the mean±standard error followed by the number of animals in parenthesis.
The effects of PCP on rat liver composition are given in Table 1 . A single dose of PCP caused statistically significant decreases in DNA contents 24-48 hours following treatment (p<0.01 or p<0.05). The hepatic protein content in the treated rats decreased at 24 hours (p<0.01), but returned to control values after 48 hours. RNA contents in the liver were unaffected by PCP.
The time course of changes in hepatic glycogen and blood sugar following PCP treatment is presented in Table 2 . PCP significantly decreased (p<0.05) the hepatic glycogen content at 3 hours, which was followed later by significantly increased storage of glycogen. On the other hand, rapid elevation of blood sugar was observed at 3 hours (p<0.01), but this elevation recovered to control levels thereafter.
Significant increases in liver weight were confimred 24-48 hours after treatment (Table 3) . PCP treatment significantly lowered hematocrit value (Ht) at 3 hours (p<0.01), which returned to the control level at 24-48 hours.
The effects of PCP on the glycolytic intermediates in rats are summarized in Table 4 . No significant differences in glycolytic intermediates in blood such as pyruvate and lactate were observed. In contrast, liver lactate elevated significantly (p<0.05) over control rat levels 24-48 hours after dosing ( Table 4) .
The effects of PCP on the adrenal functions were also investigated (Table 5 ). AAA level was significantly lowered, whereas SCS was elevated in PCP-treated rats at 3 hours; Those significant changes returned to the control levels 24 hours after treatment.
No significant changes of ACS were observed at a: PCP was administered at a single po dose of 120mg/kg to male Wistar rats. Control received an equivalent volume of distilled water. The rats were put on a fast and killed at the stated time intervals.
a: PCP was administered at a single po dose of 120mg/kg to male Wistar rats. Control received an equivalent volume of distilled water. The rats were put on a fast and killed at the stated time intervals. 3 and 24 hours. Neither right nor left adrenal weight was affected by PCP. In Table 6 are presented the activities of hepatic glycogen synthetase and phosphorylase of control and PCP-treated rats. PCP significantly enhanced phosphorylase activity at 1 (p<0.01) and 2 hours (p< 0.05), which was followed by significant decreases in hepatic glycogen at 2 (p<0.01) and 3 hours (p<0.001) after dosing. On the other hand, total glycogen synthetase and glucose-6-phosphate-independent form were markedly accelerated at 24 hours (p<0.001) in PCP-treated rats. Such an increased activity was absent in control rats.
DISCUSSION
The authors previously demonstrated that PCP, ranging in dose from 10 to 150mg/kg body weight, caused remarkable accumulation of hepatic glycogen at concentrations above 120mg/kg 24 hours after treatment.15) Consequently, effects were repeatedly examined in the present study at various times after a dose of 120mg/kg in order to examine in greater detail the PCP effects on the glycogen metabolism.
Results obtained disclosed that PCP induces two-phased reactions, i. e., early depletion and later a: PCP was administered at a single po dose of 120mg/kg to male Wistar rats. Control received an equivalent volume of distilled water. The rats were put on a fast and killed at the stated time intervals.
a: PCP was administered at a single po dose of 120mg/kg to male Wistar rats. Control received an equivalent volume of distilled water. The rats were put on a fast and killed at the stated time intervals. accumulation of hepatic glycogen during 24 hours. The biosynthesis of hepatic glycogen is accomplished through the reaction catalyzed by glycogen synthetase, the activity of which is regulated by the interconversion of the glucose-6-phosphate-dependent (D form) and the glucose-6-phosphate-independent form (I) of the enzyme.28) In addition, only I form
As indicated in Table 6 , PCP treatment markedly stimulated the activity of I form of liver glycogen synthetase at 24 hours. Accordingly, the increase in hepatic glycogen content observed in the later stage could be due to enzyme stimulation rather than glycolysis inhibition. This assumption would be collaborated by the present experimental results that there were no significant changes in glycolytic intermediate levels in the blood of PCP-treated rats (Table 4 ).
In contrast to this accumulative effect on hepatic glycogen content, PCP treatment resulted in depletion of hepatic glycogen at 2 and 3 hours.
Significant activation of phosphorylase were observed at first 1 and 2 hours prior to decreases in hepatic glycogen (Table 6 ). This action by PCP in the earlier stage would thus be due to acceleration of phosphorylase, which explains the elevated blood glucose level shown in this experiment and often pointed out by earlier studies as a characteristic response in PCPIt is interesting to note that several chemicals possessing uncoupling ability produce similar actions on glycogen metabolism, i. e., an initial fall at the earlier stage followed by an accumulation of hepatic glycogen at the later stage in rats.
Even after the experiments with dinitro-o-cresol by Barnes32) and with salicylate by Smith,33) the mechanism still remains unexplained.
Murano et al., who investigated the effects of 2, 4-dinitrophenol (DNP) on carbohydrate metabolism, concluded that the actions by DNP resulted from stimulation of adrenal activity. 34) It is well known that glucocorticoides are closely associated with carbohydrate metabolism. As shown in Table 5 , PCP elevated SCS and lowered AAA levels in the earlier stage, although these significant changes returned to control level at 24 hours.
This initial response of AAA is in agreement with experimental results with DNP by Murano et al.34) From the findings that PCP enhanced the adrenal activity, it would be reasonable to postulate that adrenal glucocorticoid may participate in this early reduction of hepatic glycogen observed in PCP-treated rats through the activation of phosphorylase. This speculation would be supported by the fact that adrenal corticosteroid treatment in adrenalectomized rats resulted in an activation of phosphorylase activity resulting in twice the normal level in the muscles35) and the liver.36) Recent histopathological studies have revealed that PCP contained small but possibly biochemically
Since several uncouplers are known to produce essentially the same effects on glycogen metabolism as PCP, the results presented in the present study may not be related to toxic impurities in PCP, but rather to the characteristic property of PCP. Among the glycolytic intermediates examined in this experiment, only the liver lactate levels rose significantly at 24-48 hours after PCP administration. The physiological significance could not be determined.
Ht value lowered at 3 hours. This lower Ht value may be related to the anemia often observed in PCP-treated rabbits.11) It was confirmed that both pure39) and technical PCP13,38) cause a significant increase in liver weight.
Since no significant increase in liver composition regarding protein, RNA and DNA content was observed in comparison with control rats, it is suggested that the increased liver weight by PCP treatment is not due to activation of cell division, but rather to the enlargement of hepatocytes reported by Greichus et al,40) from histological observation.
SUMMARY
The effect of a single dose of pentachlorophenol (PCP) was studied in fasted male Wistar rats. A marked depletion of hepatic glycogen and a significant increase of blood sugar were observed 3 hours following administration. In contrast, prolonged PCP treatment induced remarkable glycogen storage of more than 10 times the fasted control level. The enzymatic studies suggested that the early depletion of hepatic glycogen was caused by a stimulation of phosphorylase activity, which, in turn, resulted in elevation of blood glucose. Hepatic glycogen storage due to PCP at a later stage could be attributable to the acceleration of glucose-6-phosphate-independent (I) form of liver glycogen synthetase. Enhancement of adrenocortical activity observed in the early stage suggested that adrenocortical hormone plays a role in the initial fall of hepatic glycogen due to PCP.
